Arterial networks are rationalized as an intricate system of segments which serves to set blood flow magnitude and adapt its distribution dependent on local energetic demands. Arteries are described as single-layered tubes of endothelial cells surrounded by smooth muscle cells arranged in a circular fashion. Endothelial cells are arranged parallel to the axis of blood flow and as they are in intimate contact with blood, they respond to mechanical forces like shear stress. They are strongly coupled to one another, unlike smooth muscle, and thus constitute the primary pathway for electrical and chemical signals to spread along vasculature (Mironova et al., 2024). Smooth muscle cells are circumferentially arranged and retain the contractile machinery responsible for altering arterial tone. Tone within arterial networks is governed by multiple stimuli, the most important being intravascular pressure, blood flow, neural activity, and a range of endothelial derived factors. Alterations in smooth muscle [Ca²⁺] are the principal driver of arterial tone, with cytosolic levels largely set by the activity of voltage gated Ca²⁺ channels. The standard mechanistic paradigm, commonly termed electromechanical coupling, is straightforward in thought, thousands of smooth muscle cells exposed to a defined stimulus (e.g., intravascular pressure) subtly change their conductance to Na⁺, Cl⁻ or K⁺. With the aid of gap junction, charge spreads among coupled vascular cells, producing a homogenous membrane potential response that gates L- and to a lesser extent T-type Ca²⁺ channels. The ensuing cytosolic Ca²⁺ response modulates myosin light chain kinase and consequently the contractile state of smooth muscle. These integrated responses have garnered deep interrogation as they set the foundation of blood flow control and coordinate the dilations that increase tissue perfusion with rising metabolic demand. What is often overlooked in such examinations is the need to discretely tune blood flow distribution by allowing segments, in particular terminal/pre-capillary arterioles, to focally constrict independent of the broader structure (Sweeney et al., 2016; Grubb et al., 2020; Zambach et al., 2021). Such behavior is observable in isolated vessels and in-vivo to focal agent delivery, and it is insensitive to membrane potential and the influx of Ca²⁺ via L-type Ca²⁺ channels. Voltage insensitive contraction is often termed pharmacomechanical coupling, and its transduction is tied to signaling pathways activated G-protein coupled receptors.

The query addressed herein centers on how focal constrictor events can be generated independent of electromechanical coupling. Reason dictates careful consideration of pharmacomechanical coupling and the regulation of myosin light chain phosphatase (MLCP) through G_q/11 and G_12/13 coupled signal pathways (Figure 1). G_q/11 coupled receptors (e.g., α₁ adrenoreceptors) activate phospholipase C-β, the ensuing hydrolysis of phosphatidylinositol 4,5-bisphosphate leading to diacylglycerol and inositol triphosphate (IP₃) production. The former leads to the activation of protein kinase C and the phosphorylation of CPI-17, an upstream inhibitor of the MLCP catalytic subunit (PP1c). In contrast, G_12/13 coupled receptors (e.g., thromboxane A₂ receptor) activate the monomeric G-protein RhoA and then Rho-kinase to regulate the MLCP targeting subunit, MYPT1 via two key phosphorylation sites (T-697 & T-855). While MLCP inhibition is logically essential for focal vasoconstrictor control, a Ca²⁺ signal, one modest in magnitude and uncoupled to voltage, is still required for myosin light chain kinase (MLCK) activation. While the mechanistic foundation of this Ca²⁺ signal remains unsettled, it is intriguing to consider Ca²⁺ waves which originate from the sarcoplasmic reticulum (SR) and are triggered by IP₃ production and extracellular Ca²⁺ influx through an elusive Ca²⁺ permeable pore. The subsequent sections will consider the molecular identity of that Ca²⁺ permeable pore and how a voltage-insensitive Ca²⁺ source shapes focal tone development and blood flow distribution throughout integrated arterial networks.

Vascular smooth muscle retains sarcoplasmic reticulum, an internal store that releases Ca²⁺ upon activation of ryanodine or IP₃-sensitive receptors (IP₃R). Ca²⁺ release takes the form of several definable events, the two most common being “Ca²⁺ sparks” and “Ca²⁺ waves.” Ca²⁺ sparks, as discerned by Nelson et al. (1995) are focal voltage-dependent events that rapidly activate large-conductance Ca²⁺-activated K⁺ channels, thus initiate spontaneous transient outward currents (STOCs). In resistance arteries, STOCs drive a feedback hyperpolarization that moderates constriction initiated by stimuli like intravascular pressure. Ca²⁺ waves are slower events (1–3 s, duration) characterized by a wave front spreading from end-to-end within one cell and then asynchronously among neighboring cells. Their spatial/temporal heterogeneity is notably distinct from the synchronous, oscillatory behavior underpinning arterial vasomotion (Seppey et al., 2009). Asynchronous Ca²⁺ waves display voltage-insensitive properties and their abolishment moderates tone development to superfused agonist (Jaggar and Nelson, 2000; Mufti et al., 2010). Ca²⁺ waves reflect regenerative Ca²⁺-induced Ca²⁺-release among neighboring IP₃ and/or ryanodine receptors, an event dependent on IP₃ production and extracellular Ca²⁺ influx. The latter would be presumptively important to driving the initial opening of IP₃Rs or to refilling of the SR. What is the most likely identity of this Ca²⁺ permeable pore?

Fundamental understanding of vascular control is shaped by prevailing tools and the manner in which experiments are designed to probe biological behavior. In this regard, the use of vessel myography is central, as is the examination of arterial tone to agonists broadly applied to a bath. The interpretational consequence of this embedded approach is to view arterial tone as a global integrated phenomenon, among and across vessel segments, a property essential to the control of blood flow magnitude. As such, electro- and pharmaco-mechanical coupling, the latter of which incorporates receptor operated Ca²⁺ channels/Ca²⁺ sensitization, are viewed as contractile mechanisms working proportionally and synergistically with one another. Deeper examination, however, reveals a flaw in this reasoning, embodied by this query “Why are two distinct contractile mechanisms needed to regulate a singular aspect of arterial tone development and presumptively blood flow control? Indeed, integrated tone control across vessels and branch points can be achieved through electromechanical coupling alone, as charge spread through gap junctions ensures a comparable V_M and cytosolic Ca²⁺ response across thousands of smooth muscle cells. Could it be that pharmacomechanical coupling encodes for an aspect of blood flow delivery distinct from “magnitude”? Consider for example, a single terminal arteriole and the associated tuning of blood flow “distribution” within each capillary network. Local tuning presumptively requires focal vasomotor control, a response difficult to achieve via electromechanical coupling as the charge arise from a small number of activated cells gets readily diluted into the large mass of unstimulated cells to which they are coupled. It is in this context that the value of pharmacomechanical coupling, with its dependence on MLCP regulation and receptor operated Ca²⁺ channel activation, becomes evident. Although observations are limited, brain studies have noted that precapillary arterioles can operate in a sphincter-like manner as they branch from the penetrating arteriole. The mural cells embedded in these segments are intriguing in many aspects (Phillips et al., 2022), perhaps most notably herein, the robust expression of TRPC3 and TRPC6 (He et al., 2018; Vanlandewijck et al., 2018) (Figure 2). Vasomotor heterogeneity is also observable across the length of a penetrating arterioles, a behavior consistent although not definitive for, focal zones of enhanced TRPC channel expression and pharmacomechanical control (Institoris et al., 2015; Chow et al., 2020). What triggers focal vasomotor responses in organs like the brain, remains a question of active inquiry. Perhaps, a single astrocytic endfoot produces a diffusible signal from appropriate sensory input that tunes pharmacomechanical rather than electromechanical coupling. Arguably, pharmacomechanical regulation might also be achieved via direct neural synapses onto smooth muscle, regions of which have been recently identified by scanning electron microscopy (Zhang et al., 2024). The genesis of focal vasomotor tone should also be rationalized in a pathobiological context. Consider for example, cerebral arterial vasospasm, a profound local constriction induced by the extravasation of blood, and which elicits stroke-like symptoms. These deleterious responses are often refractory to L-type Ca²⁺ channel blockade, and thus presumptively pharmacomechanical in foundation. It follows that targeting key pathways and signaling proteins underpinning pharmacomechanical coupling may be of clinical benefit to appropriate patient populations.

A putative receptor activated TRPC channel in a cohort of smooth muscle cells, could serve as a Ca²⁺ source to drive SR Ca²⁺ wave generation and a local pharmacomechanical constrictor response, independent of membrane potential. Contrary to electromechanical coupling where an electrical signal integrated across vessel segments sets blood flow magnitude, local V_M-independent constriction would be presumptively designed to tune distribution. In this regard, pharmacomechanical coupling should be view as functional distinctive from electromechanical coupling but essential to the optimization of demand/supply coupling to active tissues (Figure 2). While an intriguing concept, experimental validation is essential, the first step being the identification of local constrictor sites in vivo, a process which has begun. Further, it is interesting to consider whether such sites are molecularly unique, perhaps displaying enhanced expression of receptor operated Ca²⁺ channels. One could alternatively argue that these sites of point control receive additional inputs from surrounding parenchymal cells, for example, defined astrocytic end feet or the sparely arranged interneurons in brain. Further experimentation is clearly needed to deepen insight on this novel aspect of blood flow control. Likewise, intricate computers models of contractile control, akin to those used to probe intercellular conduction in brain microvascular networks will provide further conceptual insight and set new boundaries to our understanding of blood flow coupling to energetic demands.